Simone Maschauer

Franz Josef Strauß Allee 11
Regensburg, BY 93053, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands.

High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands.

Journal: Journal of medicinal chemistry
Published: September 03, 2025

99mTc-Labeled Diarylpyrazoles for Single-Emission Computer Tomography Imaging of Neurotensin Receptor-Positive Tumors: A Comparative Preclinical Study.

99mTc-Labeled Diarylpyrazoles for Single-Emission Computer Tomography Imaging of Neurotensin Receptor-Positive Tumors: A Comparative Preclinical Study.

Journal: Pharmaceutics
Published: April 09, 2025

Radiosynthesis and Preclinical Evaluation of 18F-Labeled Estradiol Derivatives with Different Lipophilicity for PET Imaging of Breast Cancer.

Radiosynthesis and Preclinical Evaluation of 18F-Labeled Estradiol Derivatives with Different Lipophilicity for PET Imaging of Breast Cancer.

Journal: Cancers
Published: June 19, 2024

Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation.

Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation.

Journal: EJNMMI research
Published: June 07, 2024

In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer.

In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 10, 2024

Structure-guided discovery of orexin receptor-binding PET ligands.

Structure-guided discovery of orexin receptor-binding PET ligands.

Journal: Bioorganic & medicinal chemistry
Published: May 03, 2024

Bioconjugation of a Fibroblast Activation Protein Targeted Interleukin-4.

Bioconjugation of a Fibroblast Activation Protein Targeted Interleukin-4.

Journal: ACS biomaterials science & engineering
Published: September 18, 2023

CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis.

CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis.

Journal: Nature immunology
Published: March 15, 2023

Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors.

Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors.

Journal: Scientific reports
Published: May 24, 2022

Non-Invasive Characterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT.

Non-Invasive Characterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT.

Journal: Cancers
Published: April 08, 2022

N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy.

N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy.

Journal: Gastroenterology
Published: March 09, 2022

Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects.

Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 18, 2021
Showing 1-12 of 52

Last Updated: 09/26/2026